Altmeyer Mark 4
4 · Axovant Sciences Ltd. · Filed Mar 16, 2018
Insider Transaction Report
Form 4
Altmeyer Mark
Pres&Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-03-15+340,000→ 340,000 totalExercise: $1.46Exp: 2028-03-15→ Common Shares (340,000 underlying) - Award
Employee Stock Option (Right to Buy)
2018-03-15+100,000→ 100,000 totalExercise: $1.46Exp: 2028-03-15→ Common Shares (100,000 underlying)
Footnotes (3)
- [F1]The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on March 15, 2019 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
- [F2]The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F3]One-third of the option will vest at such time as the Issuer's stock price is equal to $4.38; one-third of the option will vest at such time as the Issuer's stock price is equal to $7.30, and one-third of the option will vest at such time as the Issuer's stock price is equal to $10.22, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date.